EXCITE International helps you access key decision-makers and leading world experts, and facilitates multi-jurisdictional clinical trials through our partnership with government, clinical experts, methodology centres and health system decision makers.
Applications to EXCITE International are accepted throughout the year. Promising technologies that align with our mandate of significantly impacting patient well-being and improving health system efficiencies are invited to apply. We consult with and help innovators complete and submit robust applications.
1. Early Technology Review
Requests for or discussions related to Early Technology Review should be made to Dr Les Levin at:
2. Protocol Development and Clinical Trial Application
Our current focus at EXCITE International is to evaluate innovative medical devices that can significantly improve patient outcomes and improve health system efficiencies. Both multinational enterprises (MNEs) and small and medium enterprises (SMEs) are eligible to apply to the program.
Applicant technologies may be pre-market or already licensed by regulatory organizations.
In general, the technologies should:
We do not evaluate pharmaceutical products, however, applications for companion diagnostics to inform pharmaceutical development or pharmacogenomics targeted therapies may be considered.
If you are interested in submitting an application for evaluating a promising health technology, please Contact Us or submit your application using the form below.
EXCITE International recognizes your need for privacy. By submitting personal information to EXCITE International, you agree to our collection and use of such personal information to keep a record of the applicants to the EXCITE International program and contact them with updates as we assess each application. EXCITE International will keep the personal information secure and only use or disclose it for the purposes identified above or as required by law.